Article Details

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round

Retrieved on: 2021-05-06 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round. View article details on hiswai:

Excerpt

... a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric conditions, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up